Screening mammography in older women: A review

JAMA

Volumn 311, Issue 13, 2014, Pages 1336-1347

  Walter, Louise C ^a,b   Schonberg, Mara A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; ANXIETY; BODY MASS; BONE DENSITY; BREAST BIOPSY; BREAST CANCER; BREAST FEEDING; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; ETHNICITY; FALSE POSITIVE RESULT; FAMILY HISTORY; HIGH RISK POPULATION; HUMAN; LIFE EXPECTANCY; MAMMOGRAPHY; MENARCHE; MENOPAUSE; NULLIPARA; PAIN; PATIENT DECISION MAKING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENESCENCE; SENSITIVITY AND SPECIFICITY; SMOKING; SYSTEMATIC REVIEW;

AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DECISION MAKING; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LIFE EXPECTANCY; MAMMOGRAPHY; RISK FACTORS;

EID: 84897554517     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.2834     Document Type: Review

References (97)

1. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L; US Preventive Services Task Force. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med. 2009;151(10):727-737, W237-42.
2. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778- 1786.
3. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013;6(6):CD001877.
4. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60(2):99-119.
5. American College of Obstetricians and Gynecologists Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol. 2011;118(2):372-382.
6. American College of Radiology. ACR practice guideline for the performance of screening and diagnostic mammography. http://www.acr.org/~/media/ACR/ Documents/PGTS/guidelines/Screening-Mammography.pdf. Accessed November 11, 2013.
7. Warner E, Heisey R, Carroll JC. Applying the 2011 Canadian guidelines for breast cancer screening in practice. CMAJ. 2012;184(16):1803-1807.
8. National Comprehensive Cancer Network. Breast cancer screening and diagnosis. Version 2.2013. http://www.nccn.org/professionals/physician-gls/pdf/ breast-screening.pdf. Accessed November 11, 2013.
9. National Health System. NHS breast screening programme: extending the screening age range. http://www.cancerscreening.nhs.uk/breastscreen/over-70. html. Accessed November 11, 2013.
10. US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716-726.
11. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879-1886. (Pubitemid 20026073)
12. Vacek PM, Skelly JM, Geller BM. Breast cancer risk assessment in women aged 70 and older. Breast Cancer Res Treat. 2011;130(1):291-299.
13. Cummings SR, Lee JS, Lui LY, et al. Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study. Cancer Epidemiol Biomarkers Prev. 2005;14(5):1047-1051. (Pubitemid 40656446)
14. Horn J, Åsvold BO, Opdahl S, et al. Reproductive factors and the risk of breast cancer in old age: a Norwegian cohort study. Breast Cancer Res Treat. 2013;139(1):237-243.
15. Li CI, Malone KE, Porter PL, et al. Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age. Int J Cancer. 2003;107(4): 647-651. (Pubitemid 37296128)
16. Poynter JN, Inoue-Choi M, Ross JA, et al. Reproductive, lifestyle, and anthropometric risk factors for cancer in elderly women. Cancer Epidemiol Biomarkers Prev. 2013;22(4):681-687.
17. Shantakumar S, Terry MB, Teitelbaum SL, et al. Reproductive factors and breast cancer risk among older women. Breast Cancer Res Treat. 2007;102(3):365-374. (Pubitemid 46474848)
18. Sweeney C, Blair CK, Anderson KE, et al. Risk factors for breast cancer in elderly women. Am J Epidemiol. 2004;160(9):868-875. (Pubitemid 39434771)
19. Cauley JA, Lucas FL, Kuller LH, et al. Bone mineral density and risk of breast cancer in older women: the Study of Osteoporotic Fractures. JAMA. 1996;276(17):1404-1408. (Pubitemid 26365846)
20. Ganry O, Baudoin C, Fardellone P, et al. Bone mass density and risk of breast cancer and survival in older women. Eur J Epidemiol. 2004;19(8): 785-792. (Pubitemid 41184430)
21. Zmuda JM, Cauley JA, Ljung BM, et al. Bone mass and breast cancer risk in older women: differences by stage at diagnosis. J Natl Cancer Inst. 2001;93(12):930-936. (Pubitemid 32624650)
22. Krebs EE, Taylor BC, Cauley JA, et al. Measures of adiposity and risk of breast cancer in older postmenopausal women. J Am Geriatr Soc. 2006;54(1):63-69.
23. Morimoto LM, White E, Chen Z, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control. 2002;13(8):741-751. (Pubitemid 35204050)
24. Ritte R, Lukanova A, Berrino F, et al. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status. Breast Cancer Res. 2012;14(3):R76.
25. Trentham-Dietz A, Newcomb PA, Storer BE, et al. Body size and risk of breast cancer. Am J Epidemiol. 1997;145(11):1011-1019. (Pubitemid 27215484)
26. van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152(6):514-527.
27. Yong LC, Brown CC, Schatzkin A, Schairer C. Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987-1989. Am J Epidemiol. 1996;143(10):985- 995. (Pubitemid 26140325)
28. Li CI, Malone KE, Daling JR. The relationship between various measures of cigarette smoking and risk of breast cancer among older women 65-79 years of age (United States). Cancer Causes Control. 2005;16(8):975-985. (Pubitemid 41191422)
29. Li CI, Malone KE, Porter PL, et al. The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of age. Cancer Epidemiol Biomarkers Prev. 2003;12(10):1061-1066. (Pubitemid 37310263)
30. Petri AL, Tjønneland A, Gamborg M, et al. Alcohol intake, type of beverage, and risk of breast cancer in pre- and postmenopausal women. Alcohol Clin Exp Res. 2004;28(7):1084-1090. (Pubitemid 38960788)
31. Cerhan JR, Chiu BC, Wallace RB, et al. Physical activity, physical function, and the risk of breast cancer in a prospective study among elderly women. J Gerontol A Biol Sci Med Sci. 1998;53(4):M251-M256. (Pubitemid 28354741)
32. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA. 2003;289(24):3243-3253. (Pubitemid 37430077)
33. LaCroix AZ, Chlebowski RT, Manson JE, et al; WHI Investigators. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA. 2011;305(13):1305-1314.
34. Kerlikowske K, Cook AJ, Buist DS, et al. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol. 2010;28(24):3830-3837.
35. Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011;155(1):10-20.
36. Chlebowski RT, Kuller LH, Prentice RL, et al; WHI Investigators. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 2009;360(6):573-587.
37. Data on SEER (Surveillance, Epidemiology and End Results) cancer statistics. http://seer.cancer.gov/csr/1975-2010/browse-csr.php?sectionSEL= 4&pageSEL=sect-04-table.12.html. Accessed February 14, 2014.
38. Grabler P, Dupuy D, Rai J, Bernstein S, Ansell D. Regular screening mammography before the diagnosis of breast cancer reduces black:white breast cancer differences and modifies negative biological prognostic factors. Breast Cancer Res Treat. 2012;135(2):549-553.
39. Schonberg MA, Ramanan RA, McCarthy EP, Marcantonio ER. Decision making and counseling around mammography screening for women aged 80 or older. J Gen Intern Med. 2006;21(9):979-985. (Pubitemid 44141769)
40. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001;285(21):2750-2756. (Pubitemid 32525372)
41. National Center for Health Statistics. Life Tables of the United States, 2008. http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61-03.pdf. Accessed November 11, 2013.
42. Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: a systematic review. JAMA. 2012;307(2):182-192.
43. Marmot MG, Altman DG, Cameron DA, et al. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108(11):2205-2240.
44. Badgwell BD, Giordano SH, Duan ZZ, et al. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol. 2008;26(15):2482-2488.
45. McPherson CP, Swenson KK, Lee MW. The effects of mammographic detection and comorbidity on the survival of older women with breast cancer. J Am Geriatr Soc. 2002;50(6):1061-1068. (Pubitemid 34666312)
46. McCarthy EP, Burns RB, Freund KM, et al. Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc. 2000;48(10):1226-1233.
47. Van Dijck JA, Verbeek AL, Beex LV, et al. Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality. Int J Cancer. 1996;66(6):727-731. (Pubitemid 26197938)
48. Barratt A, Howard K, Irwig L, Salkeld G, Houssami N. Model of outcomes of screening mammography: information to support informed choices. BMJ. 2005;330(7497):936.
49. Mandelblatt JS, Cronin KA, Bailey S, et al; Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151(10):738-747.
50. Braithwaite D, Zhu W, Hubbard RA, et al; Breast Cancer Surveillance Consortium. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst. 2013;105(5):334-341.
51. Schonberg MA, Silliman RA, Marcantonio ER. Weighing the benefits and burdens of mammography screening among women age 80 years or older. J Clin Oncol. 2009;27(11):1774-1780.
52. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138(3):168-175. (Pubitemid 36231622)
53. Walter LC, Eng C, Covinsky KE. Screening mammography for frail older women: what are the burdens? J Gen Intern Med. 2001;16(11):779-784. (Pubitemid 34209066)
54. Welch HG, Fisher ES. Diagnostic testing following screening mammography in the elderly. J Natl Cancer Inst. 1998;90(18):1389-1392. (Pubitemid 28439962)
55. Galit W, Green MS, Lital KB. Routine screening mammography in women older than 74 years: a review of the available data. Maturitas. 2007;57(2):109-119. (Pubitemid 46771033)
56. Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341(27):2061-2067. (Pubitemid 30035956)
57. Schonberg MA, Marcantonio ER, Li D, et al. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol. 2010;28(12):2038-2045.
58. Wildiers H, Kunkler I, Biganzoli L, et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol. 2007;8(12):1101-1115. (Pubitemid 350182967)
59. Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31(19):2382-2387.
60. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687-1717.
61. Muss HB, Berry DA, Cirrincione CT, et al; CALGB Investigators. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med. 2009;360(20):2055-2065.
62. Allegra CJ, Aberle DR, Ganschow P, et al. National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009. J Natl Cancer Inst. 2010;102(3):161-169.
63. Hurria A, Browner IS, Cohen HJ, et al. Senior adult oncology. J Natl Compr Canc Netw. 2012;10(2):162-209.
64. Lee SJ, Boscardin WJ, Stijacic-Cenzer I, Conell-Price J, O'Brien S, Walter LC. Time lag to benefit after screening for breast and colorectal cancer: a meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ. 2013;346:e8441.
65. Mandelblatt JS, Schechter CB, Yabroff KR, et al; Breast Cancer in Older Women Research Consortium. Toward optimal screening strategies for older women. J Gen Intern Med. 2005;20(6):487-496.
66. Mandelblatt JS, Wheat ME, Monane M, Moshief RD, Hollenberg JP, Tang J. Breast cancer screening for elderly women with and without comorbid conditions. A decision analysis model. Ann Intern Med. 1992;116(9):722-730. (Pubitemid 23033115)
67. Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA. 1999;282(22):2156-2163.
68. Bond M, Pavey T, Welch K, et al. Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess. 2013;17(13):1-170, v-vi.
69. Montgomery M, McCrone SH. Psychological distress associated with the diagnostic phase for suspected breast cancer: systematic review. J Adv Nurs. 2010;66(11):2372-2390.
70. Bruening W, Fontanarosa J, Tipton K, et al. Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions. Ann Intern Med. 2010;152(4): 238-246.
71. Sox HC. Screening for disease in older people. J Gen Intern Med. 1998;13(6):424-425. (Pubitemid 28294724)
72. Raik BL, Miller FG, Fins JJ. Screening and cognitive impairment: ethics of forgoing mammography in older women. J Am Geriatr Soc. 2004;52(3):440-444. (Pubitemid 38339528)
73. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605-613.
74. Puliti D, Duffy SW, Miccinesi G, et al; EUROSCREEN Working Group. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen. 2012;19(3)(suppl 1):42-56.
75. Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94(20):1546-1554. (Pubitemid 35277278)
76. Etzioni R, Gulati R, Mallinger L, Mandelblatt J. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Ann Intern Med. 2013;158(11):831-838.
77. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998-2005.
78. Barratt AL, Glasziou PP. Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment? Med J Aust. 2012;196(11):681.
79. Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2004;96(6): 443-448. (Pubitemid 38443647)
80. de Glas NA, Kiderlen M, Bastiaannet E, et al. Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis. Breast Cancer Res Treat. 2013;138(2):561-569.
81. Dijkstra JB, Houx PJ, Jolles J. Cognition after major surgery in the elderly: test performance and complaints. Br J Anaesth. 1999;82(6):867-874. (Pubitemid 29245616)
82. Muss HB, Woolf S, Berry D, et al; Cancer and Leukemia Group B. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA. 2005;293(9):1073-1081. (Pubitemid 40300281)
83. Buchholz TA. Radiation therapy for early-stage breast cancer after breast-conserving surgery. N Engl J Med. 2009;360(1):63-70.
84. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11): 987-998.
85. Hersch J, Jansen J, Barratt A, et al. Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ. 2013;346:f158.
86. Wegwarth O, Gigerenzer G. Overdiagnosis and overtreatment: evaluation of what physicians tell their patients about screening harms. JAMA Intern Med. 2013;173(22):2086-2087.
87. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71-78. (Pubitemid 38040537)
88. Torke AM, Schwartz PH, Holtz LR, Montz K, Sachs GA. Older adults and forgoing cancer screening: "I think it would be strange." JAMA Intern Med. 2013;173(7):526-531.
89. Hoffman RM, Lewis CL, Pignone MP, et al. Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey. Med Decis Making. 2010;30(5)(suppl): 53S-64S.
90. Stefanek ME. Uninformed compliance or informed choice? A needed shift in our approach to cancer screening. J Natl Cancer Inst. 2011;103(24):1821-1826.
91. Degner LF, Kristjanson LJ, Bowman D, et al. Information needs and decisional preferences in women with breast cancer. JAMA. 1997;277(18):1485- 1492. (Pubitemid 27208893)
92. Fagerlin A, Pignone M, Abhyankar P, et al. Clarifying values: an updated review. BMC Med Inform Decis Mak. 2013;13(suppl 2):s8.
93. Garcia-Retamero R, Okan Y, Cokely ET. Using visual aids to improve communication of risks about health: a review. Scientific World J. 2012;2012:562637.
94. Fagerlin A, Zikmund-Fisher BJ, Ubel PA. Helping patients decide: ten steps to better risk communication. J Natl Cancer Inst. 2011;103(19):1436-1443.
95. Peters E, Diefenbach MA, Hess TM, Västfjäll D. Age differences in dual information-processing modes: implications for cancer decision making. Cancer. 2008;113(12)(suppl):3556-3567.
96. Morrow DG, Leirer VO, Andrassy JM, Hier CM, Menard WE. The influence of list format and category headers on age differences in understanding medication instructions. Exp Aging Res. 1998;24(3):231-256. (Pubitemid 28277466)
97. ePrognosis. Estimating prognosis for elders. http://www.eprognosis.org. Accessed February 14, 2014.